Braking the cycle: Inhibition of the cyclin D-Cdk4/6 pathway in breast cancer

被引：4
|
作者：
Abraham, Robert T. [1 ]
VanArsdale, Todd [1 ]
Shields, David V. [1 ]
Lee, Nathan V. [1 ]
Koehler, Maria [2 ]
Arndt, Kim [2 ]
机构：
[1] Pfizer Worldwide Res & Dev, Pfizer Oncol Res Unit, San Diego, CA USA
[2] Pfizer Oncol, San Diego, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-SY34-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY34-03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition
    Guo, Xianan
    Chen, Huihui
    Zhou, Yunxiang
    Shen, Lu
    Wu, Shijie
    Chen, Yiding
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (09) : 933 - 944
  • [32] Mechanisms of therapeutic CDK4/6 inhibition in breast cancer
    Scott, Susan Combs
    Lee, Sarah S.
    Abraham, Jame
    [J]. SEMINARS IN ONCOLOGY, 2017, 44 (06) : 385 - 394
  • [33] Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin
    Bryja, V.
    Pachernik, J.
    Vondracek, J.
    Soucek, K.
    Cajanek, L.
    Horvath, V.
    Holubcova, Z.
    Dvorak, P.
    Hampl, A.
    [J]. CELL PROLIFERATION, 2008, 41 (06) : 875 - 893
  • [34] Inhibition of Cyclin-Dependent Kinases 4 and 6 in Breast Cancer
    Mayer, Erica L.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (04) : 215 - 217
  • [35] Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix
    Topacio, Benjamin R.
    Zatulovskiy, Evgeny
    Cristea, Sandra
    Xie, Shicong
    Tambo, Carrie S.
    Rubin, Seth M.
    Sage, Julien
    Koivomagi, Mardo
    Skotheim, Jan M.
    [J]. MOLECULAR CELL, 2019, 74 (04) : 758 - +
  • [36] CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
    Goel, Shom
    DeCristo, Molly J.
    McAllister, Sandra S.
    Zhao, Jean J.
    [J]. TRENDS IN CELL BIOLOGY, 2018, 28 (11) : 911 - 925
  • [37] CDK4/6 inhibition in cancer: the cell cycle splicing connection
    Sheppard, Karen E.
    AbuHammad, Shatha
    [J]. MOLECULAR & CELLULAR ONCOLOGY, 2019, 6 (06)
  • [38] Switching ceyclin D-Cdk4 kinase activity on and off
    Blain, Stacy W.
    [J]. CELL CYCLE, 2008, 7 (07) : 892 - 898
  • [39] Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
    Piezzo, Michela
    Cocco, Stefania
    Caputo, Roberta
    Cianniello, Daniela
    Di Gioia, Germira
    Di Lauro, Vincenzo
    Fusco, Giuseppina
    Martinelli, Claudia
    Nuzzo, Francesco
    Pensabene, Matilde
    De Laurentiis, Michelino
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 23
  • [40] Combined inhibition of CDK2 and CDK4/6 overcomes acquired resistance to CDK4/6 inhibitors in breast cancer via RB-independent pathway
    Pandey, Kamal
    [J]. CANCER RESEARCH, 2020, 80 (16)
12345